2,4-thiazolidinedione has been researched along with Pneumonia, Viral in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dambha-Miller, H | 1 |
| Albasri, A | 1 |
| Hodgson, S | 1 |
| Wilcox, CR | 1 |
| Khan, S | 1 |
| Islam, N | 1 |
| Little, P | 1 |
| Griffin, SJ | 1 |
1 review available for 2,4-thiazolidinedione and Pneumonia, Viral
| Article | Year |
|---|---|
Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inh | 2020 |